385 related articles for article (PubMed ID: 36560730)
1. Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.
Wang WC; Sayedahmed EE; Mittal SK
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560730
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral vector immunity: its implications and circumvention strategies.
Ahi YS; Bangari DS; Mittal SK
Curr Gene Ther; 2011 Aug; 11(4):307-20. PubMed ID: 21453277
[TBL] [Abstract][Full Text] [Related]
3. Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model.
Hrycak CP; Windmann S; Bayer W
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375593
[TBL] [Abstract][Full Text] [Related]
4. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
Sayedahmed EE; Kumari R; Shukla S; Hassan AO; Mohammed SI; York IA; Gangappa S; Sambhara S; Mittal SK
Vaccine; 2018 Oct; 36(45):6744-6751. PubMed ID: 30266488
[TBL] [Abstract][Full Text] [Related]
5. Circumventing antivector immunity: potential use of nonhuman adenoviral vectors.
Lopez-Gordo E; Podgorski II; Downes N; Alemany R
Hum Gene Ther; 2014 Apr; 25(4):285-300. PubMed ID: 24499174
[TBL] [Abstract][Full Text] [Related]
6. Current strategies and future directions for eluding adenoviral vector immunity.
Bangari DS; Mittal SK
Curr Gene Ther; 2006 Apr; 6(2):215-26. PubMed ID: 16611043
[TBL] [Abstract][Full Text] [Related]
7. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
J Virol; 2020 May; 94(10):. PubMed ID: 32102889
[TBL] [Abstract][Full Text] [Related]
8. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
[TBL] [Abstract][Full Text] [Related]
9. Development of nonhuman adenoviruses as vaccine vectors.
Bangari DS; Mittal SK
Vaccine; 2006 Feb; 24(7):849-62. PubMed ID: 16297508
[TBL] [Abstract][Full Text] [Related]
10. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
Seiler MP; Cerullo V; Lee B
Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector system: construction, history and therapeutic applications.
Syyam A; Nawaz A; Ijaz A; Sajjad U; Fazil A; Irfan S; Muzaffar A; Shahid M; Idrees M; Malik K; Afzal S
Biotechniques; 2022 Dec; 73(6):297-305. PubMed ID: 36475496
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen.
Haq K; Jia Y; Elahi SM; MacLean S; Akache B; Gurnani K; Chattopadhyay A; Nazemi-Moghaddam N; Gilbert R; McCluskie MJ; Weeratna RD
Vaccine; 2019 Nov; 37(47):7029-7040. PubMed ID: 31506193
[TBL] [Abstract][Full Text] [Related]
13. A rapid protocol for construction and production of high-capacity adenoviral vectors.
Jager L; Hausl MA; Rauschhuber C; Wolf NM; Kay MA; Ehrhardt A
Nat Protoc; 2009; 4(4):547-64. PubMed ID: 19373227
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL.
Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK
Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617
[TBL] [Abstract][Full Text] [Related]
15. EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo.
Chu Q; St George JA; Lukason M; Cheng SH; Scheule RK; Eastman SJ
Hum Gene Ther; 2001 Mar; 12(5):455-67. PubMed ID: 11268280
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector.
Sayedahmed EE; Elshafie NO; Zhang G; Mohammed SI; Sambhara S; Mittal SK
Front Immunol; 2023; 14():1305937. PubMed ID: 38077380
[TBL] [Abstract][Full Text] [Related]
17. Helper-dependent adenoviral vectors for liver-directed gene therapy.
Brunetti-Pierri N; Ng P
Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
[TBL] [Abstract][Full Text] [Related]
18. Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.
Lemiale F; Kong WP; Akyürek LM; Ling X; Huang Y; Chakrabarti BK; Eckhaus M; Nabel GJ
J Virol; 2003 Sep; 77(18):10078-87. PubMed ID: 12941918
[TBL] [Abstract][Full Text] [Related]
19. Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination.
Zhang W; Fu J; Ehrhardt A
Hum Gene Ther Methods; 2018 Jun; 29(3):124-134. PubMed ID: 29756505
[TBL] [Abstract][Full Text] [Related]
20. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses.
Roth MD; Cheng Q; Harui A; Basak SK; Mitani K; Low TA; Kiertscher SM
J Immunol; 2002 Oct; 169(8):4651-6. PubMed ID: 12370405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
